ERYTHROMYCIN ETHYLSUCCINATE
NDC 52536-132, Erythromycin Ethylsuccinate, suspension, from Wilshire Pharmaceuticals.
- Product NDC
- 52536-132
- Status
- Listed
- Labeler
- Wilshire Pharmaceuticals
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA050207
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52536-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERYTHROMYCIN ETHYLSUCCINATE200 mg/5mL
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52536-132-13 | 52536013213 | 100 mL in 1 BOTTLE (52536-132-13) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/86d6353c-2b58-4219-b31d-fb5b97789094NADAC price for package 52536013213
GET /v1/drugs/nadac/52536013213
Use it
Look up 52536-132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52536-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52536-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.